Advances in the study of polysaccharide-based hydrogel wound dressings
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142134 - 142134
Published: March 1, 2025
Language: Английский
Emerging roles of hyaluronic acid hydrogels in cancer treatment and wound healing: A review
Gang Wu,
No information about this author
Chunyan Zhong,
No information about this author
Xiaohui Tian
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 140442 - 140442
Published: Jan. 1, 2025
Language: Английский
Research progress of porous drug carriers in tumor diagnosis and therapy
Li Zhu,
No information about this author
Xinyuan Li,
No information about this author
Fei Yin
No information about this author
et al.
Macromolecular Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 11, 2025
Language: Английский
Preparation of environmentally responsive PDA&DOX@LAC live drug carrier for synergistic tumor therapy
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: July 10, 2024
Abstract
The
development
of
intelligent,
environmentally
responsive
and
biocompatible
photothermal
system
holds
significant
importance
for
the
combined
therapy
tumors.
In
this
study,
inspired
by
Lactobacillus
(LAC),
we
prepared
a
biomimetic
nanoplatform
PDA&DOX@LAC
tumor
photothermal-chemotherapy
integrating
chemotherapeutic
drug
doxorubicin
(DOX)
with
dopamine
through
oxidative
polymerization
to
form
polydopamine
(PDA)
on
surface
LAC.
not
only
achieves
precise
controlled
release
DOX
based
slightly
acidic
microenvironment
tissues,
but
also
exhibits
enzyme-like
properties
alleviate
hypoxia.
Under
near-infrared
light
irradiation,
it
effectively
induces
ablation
cells,
enhances
cellular
uptake
increasing
temperature,
thus
efficiently
inhibits
cell
growth.
Moreover,
is
further
confirmed
in
vivo
experiments
that
cells
apoptosis,
releases
tumor-associated
antigens,
which
engulfed
dendritic
activate
cytotoxic
T
lymphocytes,
thereby
suppressing
growth
prolonging
survival
period
4T1
tumor-bearing
mice.
Therefore,
immense
potential
targeting
as
well
provides
valuable
insights
theoretical
foundations
novel
treatment
strategies
endogenous
substances
within
body.
Language: Английский
Environment-responsive dopamine nanoplatform for tumor synergistic therapy
Chunmin Deng,
No information about this author
Hao Zhang,
No information about this author
Song Li
No information about this author
et al.
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Aug. 5, 2024
Nanoparticle-based
photothermal
therapy
(PTT)
has
emerged
as
a
promising
approach
in
tumor
treatment
due
to
its
high
selectivity
and
low
invasiveness.
However,
the
penetration
of
near-infrared
light
(NIR)
is
limited,
leading
it
fails
induce
damage
deep-seated
cells
within
tissue.
Additionally,
inefficient
uptake
nanoparticles
by
results
suboptimal
outcomes
for
PTT.
In
this
study,
we
utilized
adhesive
properties
material,
polydopamine
(PDA),
which
can
successfully
load
photosensitizer
indocyanine
green
(ICG)
chemotherapeutic
drug
doxorubicin
(DOX)
achieve
chemotherapy
synergy
(PDA/DOX&ICG),
aiming
compensate
defects
single
treatment.
To
extending
blood
circulation
time
PDA/DOX&ICG
nanoparticles,
evading
clearance
body
immune
system
achieving
targeted
delivery
tissues,
protective
envelopment
was
created
using
erythrocyte
membranes
modified
with
folate
acid
(FA-EM).
After
reaching
tissue,
obtained
FA-EM@PDA/DOX&ICG
specific
bind
receptors
on
surface
cells,
improve
behavior
release
loaded
DOX
ICG
response
unique
microenvironment.
ICG,
typical
photosensitizer,
significantly
enhances
conversion
performance
thus
inducing
damage.
vitro
vivo
experimental
demonstrated
that
coordinated
NIR
not
only
effectively
inhibits
growth,
but
also
exhibits
superior
biocompatibility,
mitigating
DOX-induced
tissue
Language: Английский
Research progress on the ‘all-in-one’ photothermal platform prepared based on polydopamine for tumor synergy therapy
Polymer Bulletin,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 29, 2024
Language: Английский
Biomimetic intelligent nanoplatform with cascade amplification effect for tumor synergy therapy
Ying Wang,
No information about this author
Qing Ji,
No information about this author
Chao Yan
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 20, 2024
Abstract
Tumor
heterogeneity,
immune-suppressive
microenvironment
and
the
precise
killing
of
tumor
cells
by
drugs
are
important
factors
affecting
treatment.
In
this
study,
an
environment-responsive
therapeutic
nanoplatform
based
on
metal-organic
frameworks
(FM@IQ/PST&ZIF-8/DOX)
is
developed.
Under
near-infrared
(NIR)
irradiation,
it
realizes
combined
treatment
photothermal/immunotherapy/chemotherapy,
compensating
for
deficiencies
each
single
effectively
achieving
cascade
effect
When
enters
blood
circulation,
surface-modified
erythrocyte
cell
membrane
can
disguise
itself,
avoiding
its
elimination
body
immune
system.
Moreover,
folic
acid
molecules
specific
binding
with
receptors
surface
cells,
increasing
uptake
to
them
thereby
promoting
accumulation
in
tissues.
NIR
induces
apoptosis
releases
tumor-associated
antigen,
solving
problem
poor
caused
heterogeneity.
Subsequently,
slightly
acidic
cause
framework
FM@IQ/PST&ZIF-8/DOX
collapse,
release
imiquimod
doxorubicin.
platform,
imiquimod,
as
a
small
molecule
modulator,
improve
immunosuppressive
microenvironment,
stimulate
body's
anti-tumor
response
inhibit
recurrence
metastasis
tumors.
Therefore,
novel
drug
delivery
system
designed
research
not
only
achieve
controllable
release,
but
also
microenvironment.
It
expected
become
promising
new
strategy
provide
corresponding
inspiration
later
development
drugs.
Language: Английский
Fe-coordinated carbon dots with single atom nanozyme catalytic activity for synergistic catalytic/chemo-therapy in breast cancer
Mengke Lu,
No information about this author
Jianxia Ding,
No information about this author
Yupeng Zhang
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
unknown, P. 137776 - 137776
Published: Nov. 1, 2024
Language: Английский
A review of carbohydrate polymer-synthesized nanoparticles in cancer immunotherapy: Past, present and future perspectives
Chunyan Wang,
No information about this author
Xueyao Zhang,
No information about this author
Qiaobei Li
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
286, P. 138195 - 138195
Published: Dec. 5, 2024
Language: Английский
Biomimetic intelligent nanoplatform with cascade amplification effect for tumor synergy therapy
Ying Wang,
No information about this author
Qing Ji,
No information about this author
Chao Yan
No information about this author
et al.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 28, 2024
Tumor
heterogeneity,
immune-suppressive
microenvironment
and
the
precise
killing
of
tumor
cells
by
drugs
are
important
factors
affecting
treatment.
In
this
study,
we
developed
environment-responsive
drug
delivery
system
(FM@IQ/PST&ZIF-8/DOX)
based
on
ZIF-8
for
photothermal/immunotherapy/chemotherapy
synergistic
therapy.
The
prepared
FM@IQ/PST&ZIF-8/DOX
nanoplatfrom
not
only
has
highly
loading
capacity
chemotherapeutic
drug-doxorubicin,
but
also
erythrocyte
membrance
modified
their
surface
can
endow
immunity-escaping
property
prolong
blood
circulation
time.
More
important,
neurotransmitter
serotonin
was
encapsulated
ZIF-8/DOX
oxidative
polymerization,
which
effectively
avoid
premature
leakage
DOX
in
circulation.
And
formed
polyserotonin
shell
superior
photothermal
conversion
performance,
as
well
adsorption
utilized
to
load
imiqumod.
When
entered
tissue,
folate
molecules
specifically
bind
receptors
improve
uptake
cells.
vitro
vivo
results
showed
that
nanoplatform
could
generate
a
large
amount
heat
under
near-infrared
light
irradiation,
then
induce
apoptosis
cells,
release
associated
antigens,
solve
problem
heterogeneity.
addition,
loaded
imiquimod
immunosuppressive
microenvironment,
enhance
body's
anti-tumor
immune
response,
inhibit
metastasis
recurrence.
Therefore,
novel
designed
research
achieve
controllable
release,
it
is
expected
become
promising
new
strategy
treatment
provide
corresponding
inspiration
later
development
drugs.
Language: Английский